Anzeige
Mehr »
Donnerstag, 05.06.2025 - Börsentäglich über 12.000 News
Kupfer wird knapp! Jetzt mischen sich Medien ein - und ein Explorer liefert die Story zur Fantasie
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40PMQ | ISIN: CA58471K2020 | Ticker-Symbol: N460
Frankfurt
05.06.25 | 09:59
2,180 Euro
+0,93 % +0,020
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
MEDICUS PHARMA LTD Chart 1 Jahr
5-Tage-Chart
MEDICUS PHARMA LTD 5-Tage-Chart

Aktuelle News zur MEDICUS PHARMA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoMedicus Pharma Ltd. - 8-K, Current Report-
MoMedicus Pharma schließt öffentliches Angebot über 7 Millionen US-Dollar ab1
MoMedicus Pharma completes $7 million public offering1
MoMedicus Pharma Ltd. Announces Closing of $7.0 Million Public Offering249Philadelphia, Pennsylvania--(Newsfile Corp. - June 2, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) (the "Company") today announced the closing of its previously announced public offering of 2,260,000...
► Artikel lesen
FrPre-market Movers: Bolt Projects, Basel Medical Group, Red Robin Gourmet Burgers, LZ Technology, Medicus Pharma592OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 06.55 A.M. ET).In the Green Bolt Projects Holdings, Inc. (BSLK) is up over 114%...
► Artikel lesen
MEDICUS PHARMA Aktie jetzt für 0€ handeln
FrMedicus Pharma prices $7 million share offering1
FrMedicus Pharma Ltd. Announces Pricing of $7.0 Million Public Offering300Philadelphia, Pennsylvania--(Newsfile Corp. - May 29, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) (the "Company") today announced the pricing of its public offering of 2,260,000 units, on a "best-efforts"...
► Artikel lesen
27.05.Medicus Pharma Ltd. - S-1, General form for registration of securities1
22.05.Medicus Pharma Ltd.: Medicus Pharma Ltd Receives Study May Proceed Approval from United Arab Emirates (UAE) Department of Health (DOH) to Commence Phase 2 Clinical Study (SKNJCT-004) to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)310Philadelphia, Pennsylvania--(Newsfile Corp. - May 22, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is pleased to announce that it has received study may proceed approval...
► Artikel lesen
12.05.Medicus Pharma Ltd. - 10-Q, Quarterly Report2
12.05.Medicus Pharma's 'Savvy' Antev Deal De-Risks Pipeline Expansion, Enhances Near-Commercial Portfolio3
12.05.Medicus Pharma stock target lifted to $27 on Antev acquisition2
05.05.Medicus Pharma Ltd. - 8-K, Current Report-
30.04.Medicus Pharma Ltd. - 10-K/A, Annual Report3
28.04.Medicus Pharma Ltd. - 8-K, Current Report2
28.04.Medicus Pharma to acquire Antev for $75M in share exchange transaction1
28.04.Medicus Pharma übernimmt Antev in strategischem Biotech-Deal1
28.04.Medicus Pharma to acquire Antev in strategic biotech deal4
28.04.Medicus Pharma Ltd. Announces a Binding Letter of Intent to Acquire Antev Ltd. for ~US$75 Million in a Share Exchange Transaction211Antev is developing Teverelix, A next generation GnRH Antagonist, as first in class market product for Acute Urinary Retention (AUR) and high CV risk Prostate CancerPhiladelphia, Pennsylvania--(Newsfile...
► Artikel lesen
21.04.Medicus Pharma expands patient enrollment for skin cancer study4
Seite:  Weiter >>
63 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1